Dr. Cotton is an associate at the Novartis Venture Fund (NVF) in Cambridge, Massachusetts. Before joining NVF, he worked in the labs of Jim Wells and Ian Seiple on antibody engineering research. Dr. Cotton is a scientific co-founder of Epi Biologics and he helped build Rezo Therapeutics and HYKU Biosciences as they transitioned from their respective academic labs. He holds a B.A. in chemistry from Harvard University, an MBA from the University of New Mexico, and a Ph.D. in chemistry and chemical biology from the University of California, San Francisco.